Beijing Lint Pharmaceutical Technology Co., Ltd., Elravie Ailiwei, is a brand of cross-linked sodium hyaluronate gel for injection that was developed and produced by HUONS Company, a large sodium hyaluronate raw material pharmaceutical company in South Korea, and was approved for import earlier

Elravie comes from HUONS, a 50-year-old Korean sodium hyaluronate raw material pharmaceutical company, which was established in July 1965 and obtained the Korean KGMP certification in December 1993. In June 2003, it was the first company in Korea to develop hyaluronic acid; December 2006 Listed on KOSDAQ Korea Stock Exchange and made its initial public offering. It is an enterprise that mainly develops, produces and sells products, and is mainly committed to the commercial research, production and sales of medical beauty products, cosmetics, ophthalmic drugs, anesthetics, disinfectants, etc. It not only produces hyaluronic acid raw materials, but also exports raw materials to many countries such as Europe and the United States.

HUONS has a number of subsidiaries, among which HUMEDIX specializes in the production of Alivi and PANACE produces the Demasa Hydro Injection Device.

Alivi is a new generation of single-phase hyaluronic acid, which is different from the common biphasic particle suspension preparations on the market, in the form of a smooth and homogeneous gel, and the effect of the smooth homogeneous gel-like hyaluronic acid product usually lasts longer than that of the granular product. In addition, Aliwei also has the characteristics of good shaping effect, no displacement and no deformation, and has obtained authoritative certifications such as CFDA, KFDA, CE and so on.